TABLE 2.
Fold induction of known NRF2 target gene transcripts in liver of wild-type, Keap1 C151S mutant, and Nrf2-knockout (KO) mice following one or three doses of vehicle or 30 µmol/kg CDDO-Me
| Nqo1 | Gstm1 | Gpx2 | Srnx1 | Cbr3 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Dose | 3 Doses | 1 Dose | 3 Doses | 1 Dose | 3 Doses | 1 Dose | 3 Doses | 1 Dose | 3 Doses | ||
| Wild-type | Vehicle | 1 ± 0.48a | 1 ± 0.36 | 1 ± 0.15 | 1 ± 0.41 | 1 ± 0.26 | 1 ± 0.24 | 1 ± 0.14 | 1 ± 0.37 | 1 ± 0.10 | 1 ± 0.47 |
| CDDO-Me | 7.93 ± 1.25b | 7.06 ± 1.20b | 3.49 ± 1.23b | 3.25 ± 0.67b | 4.54 ± 0.64b | 13.09 ± 3.71b | 4.59 ± 1.37b | 3.04 ± 0.79b | 43.70 ± 13.72b | 69.50 ± 30.57b | |
| C151S | Vehicle | 0.56 ± 0.05 | 0.68 ± 0.43 | 0.42 ± 0.20 | 1.1 ± 1.10 | 0.59 ± 0.08 | 0.99 ± 0.50 | 0.32 ± 0.08 | 1.05 ± 0.88 | 0.53 ± 0.16 | 1.05 ± 0.99 |
| CDDO-Me | 0.62 ± 0.11 | 0.55 ± 0.44 | 0.31 ± 0.11 | 0.42 ± 0.20 | 0.60 ± 0.17 | 0.60 ± 0.22 | 0.41 ± 0.20 | 1.14 ± 0.31 | 0.60 ± 0.10 | 0.70 ± 0.13 | |
| NRF2KO | Vehicle | 0.07 ± 0.03 | 0.11 ± 0.02 | 0.07 ± 0.02 | 0.16 ± 0.02 | 0.46 ± 0.16 | 0.38 ± 0.09 | 0.17 ± 0.02 | 0.31 ± 0.11 | 0.18 ± 0.04 | 0.30 ± 0.08 |
| CDDO-Me | 0.14 ± 0.07 | 0.11 ± 0.04 | 0.05 ± 0.01 | 0.11 ± 0.42 | 0.42 ± 0.04 | 0.39 ± 0.06 | 0.37 ± 0.18 | 0.26 ± 0.09 | 0.33 ± 0.19 | 0.52 ± 0.09b |
aAll values for gene expression levels are shown as mean ± S.D. (N = 3).
bP < 0.05 using t test. After controlling for 30 multiple comparisons with Bonferroni correction, only Nqo1 (one and three doses) reached statistical significance (P < 0.00167).